Sun Pharmaceutical Industries Ltd

  • BSE Code : 524715
  • NSE Symbol : SUNPHARMA
  • ISIN : INE044A01036
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,629.70 -77.00(-4.51%)

Open Price ()

1,690.00

Prev. Close ()

1,706.70

Volume (No’s)

8,774,548

Market Cap ()

391,019.62

Low Price ()

1,608.00

High Price ()

1,695.00

 

Profit and Loss

 Mar 2025 (.Cr) Mar 2024 (.Cr) Mar 2023 (.Cr) Mar 2022 (.Cr) Mar 2021 (.Cr) Mar 2020 (.Cr)
INCOME :      
Sales Turnover 23,003.3320,275.1720,812.1415,585.9814,116.0512,531.93
Excise Duty0.000.000.000.000.000.00
Net Sales23,003.3320,275.1720,812.1415,585.9814,116.0512,531.93
Other Income 623.97553.48329.291,196.88192.071,510.92
Stock Adjustments 69.17-180.32237.93183.18179.64-138.60
Total Income23,696.4720,648.3321,379.3616,966.0414,487.7613,904.25
EXPENDITURE :      
Raw Materials 6,050.205,423.796,292.095,833.575,287.124,429.12
Power & Fuel Cost435.72450.42495.21422.33384.16394.74
Employee Cost 2,608.262,373.952,156.952,000.781,805.981,702.77
Other Manufacturing Expenses 1,261.721,195.301,037.321,064.32862.12860.05
Selling & Administrative Expenses 5,539.894,754.864,326.423,514.053,309.621,919.25
Miscellaneous Expenses 638.63615.663,257.272,086.08479.24375.75
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure16,534.4214,813.9817,565.2614,921.1312,128.249,681.68
Operating Profit7,162.055,834.353,814.102,044.912,359.524,222.57
Interest 893.21784.08472.18388.10267.52408.01
Gross Profit6,268.845,050.273,341.921,656.812,092.003,814.56
Depreciation1,238.271,600.621,600.871,349.951,236.43561.56
Profit Before Tax5,030.573,449.651,741.05306.86855.573,253.00
Tax908.62546.10752.77-553.58244.91386.46
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-160.6745.37-702.44960.43-231.74-344.60
Reported Net Profit4,282.622,858.181,690.72-99.99842.403,211.14
Extraordinary Items 7.08-193.46-1,665.671,237.51-63.64193.27
Adjusted Net Profit4,275.543,051.643,356.39-1,337.50906.043,017.87
Adjustment below Net Profit -11.87-19.867.38-14.532,675.94-211.52
P & L Balance brought forward12,731.0412,790.8813,612.0815,964.5514,005.2712,384.61
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 3,613.972,898.162,519.302,237.951,559.061,378.96
P & L Balance carried down13,387.8212,731.0412,790.8813,612.0815,964.5514,005.27
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1,600.001,350.001,150.001,000.00750.00400.00
Dividend Per Share(Rs)16.0013.5011.5010.007.504.00
Earnings Per Share-Unit Curr17.8511.917.05-0.423.5113.38
Earnings Per Share(Adj)-Unit Curr17.8511.917.05-0.423.5113.38
Book Value-Unit Curr101.4598.7698.98102.48112.28101.68
Book Value(Adj)-Unit Curr101.4598.7698.98102.48112.28101.68

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew